Back to the main directory
SurveyAnalysisAndResults / Equity
- Vinci : Feedback réunion d’analystes après des résultats solides by Oddo BHF
- ENI SpA : Déception sur le résultat mais EBIT et cash-flow rassurant by Oddo BHF
- Réunion de la Fed, Emploi/Salaires US, Croissance du PIB/Inflation UEM by Oddo BHF
- Fed meeting, US employment/wages, Eurozone GDP growth/inflation by Oddo BHF
- ODDO : Italian banks - Q2 2018 earnings previews by Oddo BHF
- Proximus : Excellent T2 mais non extrapolable au S2 by Oddo BHF
- M6 : Cession des Girondins de Bordeaux pour 100 M€, quels réinvestissements à venir ? by Oddo BHF
- ENI SpA : Disappointment on earnings but reassuring EBIT and cash flow by Oddo BHF
- Proximus : Excellent Q2 but performance cannot be extrapolated to H2 by Oddo BHF
- Sopra Steria Group : Sanction très exagérée, avec 60% de la valorisation implicite de SBS envolée by Oddo BHF
- Indra Sistemas : A reassuring publication in several respects by Oddo BHF
- Mediaset : H1 results in line with forecasts, good momentum on advertising by Oddo BHF
- M6 : Sale of the Girondins de Bordeaux for € 100m, how will the proceeds be reinvested in the future? by Oddo BHF
- Imerys : H1 2018 results broadly in line, proppants business under review by Oddo BHF
- BBVA : Favourable Q2 2018 numbers but risks intact by Oddo BHF
- AstraZeneca : AstraZeneca - 30 July 2018 by Oddo BHF
- Siemens : Siemens - 30 July 2018 by Oddo BHF
- SES : Bon T2, augurant d’un bon S2. Mais prudence sur la Vidéo à moyen terme by Oddo BHF
- SES : Good Q2, augurs well for H2. But caution on video arm in the medium term by Oddo BHF
- AstraZeneca : AstraZeneca - 30 juillet 2018 by Oddo BHF
- Siemens : Siemens - 30 juillet 2018 by Oddo BHF
- Danone : Des points d’inflexion encourageants au S1 by Oddo BHF
- GRAMMER AG : Target price raised on revised estimates; Q2 2018e preview by Oddo BHF
- CNP Assurances : Résultat proche des attentes, les grands sujets stratégiques restent à préciser by Oddo BHF
- CNP Assurances : Net profit close to expectations, major strategic questions yet to be clarified by Oddo BHF